Impact Analysis of Covid-19 The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. Request Sample

Ambulatory Blood Pressure Monitors Market – Insights

Ambulatory blood pressure monitors (ABPM) market is expected to witness increasing demand owing to the increasing demand for self-health monitoring devices to record the blood pressure. Further, Ambulatory blood pressure monitors are also used in pharmaceutical companies to check the efficacy of hypertensive and anti-hypertensive drugs under development for cardiac health. For instance, in April 2013, ERT Clinical, a provider of high-quality patient safety and efficacy data collection solutions for use in clinical drug development, announced the availability of a centralized ABPM solution in US. ABPM enables biopharmaceutical companies to efficiently evaluate the efficacy and cardiac safety of both hypertensive and anti-hypertensive drugs as well as endpoints for cardiovascular and cerebrovascular outcomes.

ABPMs are used for monitoring the blood pressure readings of a patient recorded over a 24-hour period as the patient move around and carrying out daily life activities. Ambulatory blood pressure monitors are mainly used for indications such as white coat hypertension, nocturnal hypertension, masked hypertension, and paroxysmal hypertension. These monitor allows regular monitoring of blood pressure levels in the body at specific time intervals, which ranges from 15 to 30 minutes. It provides detailed information about the changes in blood pressure readings, which is correlated to the daily activities and sleeping patterns of individuals. Lower rate of misdiagnosis, continuous monitoring, and accurate blood pressure profiling are the major advantages of ambulatory devices in comparison to conventional blood pressuring techniques.

The global ambulatory blood pressure monitors market size was valued at US$ 1,135.64 million in 2018, and is expected to exhibit a CAGR of 7.9% over the forecast period (2019 – 2027).

Global Ambulatory Blood Pressure Monitors Market Share (%) Analysis, By Product Type, 2019

Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of hypertension is expected to drive growth of the ambulatory blood pressure monitors market

Growing geriatric population and increasing population following unhealthy lifestyles such as alcohol consumption and smoking are the major factors, which is expected to drive the market growth. This target population is highly prone to high blood pressure and are at risk of hypertension, which is inadvertently driving demand for blood pressure monitors.

According to the report by the World Heart Federation, 970 million people across the globe suffered from elevated blood pressure in 2015. Out of 970 million people, around 330 million people suffered from hypertension in developed countries, while remaining 640 million were from emerging economies. Certain preventive measures accompanying regular monitoring of the blood pressure can make a significant difference in treatment of hypertension. The blood pressure monitoring can be easily carried out with wearable and ambulatory blood pressure monitoring devices, which will drive growth of the global market.

Obesity is linked to higher incidence rate of hypertension. Moreover, excess weight gain is associated with higher visceral adiposity, which accounts for 65% to 75% of the risk for primary hypertension. For instance, according to the World Health Organization 2016, globally around 1.9 billion adults were overweight, of which, over 650 million people were obese.

Ambulatory Blood Pressure Monitors Market - Restraints

Challenges in ambulatory blood pressure monitors include product failure and inconsistency in the product component. This leads to Food and Drug Administration recalls, which in turn hampers growth of the ambulatory blood pressure monitors market. For instance, in June 2018, U.S. FDA recalled BPM+ wireless blood pressure monitor, which was manufactured by France-based Company Withings. The device was recalled as, the device could not cater to the requirements of measuring systolic pressure accurately and certain inconsistency was observed in the control system.

Ambulatory Blood Pressure Monitors Market - Regional Insights

On the basis of region, the global ambulatory blood pressure monitors market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global ambulatory blood pressure monitors market, owing to rising awareness about personalized and portable devices for blood pressure monitoring system among the population, which in turn increases demand for these devices. For instance, according to the National Center for Chronic Disease Prevention and Health Promotion, in 2017, various campaigns such as Million Hearts, Well-integrated Screening And Evaluation For Women Across The Nation (WISEWOMAN), and Sodium Reduction in Communities Program (SRCP) were launched to reduce mortality rate of the population due to hypertension through spreading awareness about impact of hypertension on health, which in turn increased the sale of portable devices for blood pressure monitoring in the U.S.

Asia Pacific market is expected to witness significant growth over the forecast period, owing to rising obesity in children of Asia Pacific. For instance, according to the World Health Organization 2016, around 41 million children under the age of 5 were obese, which accounted for about 50% of the total children in Asia Pacific.

Global Ambulatory Blood Pressure Monitors Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Source: Coherent Market Insights Analysis (2019)

Ambulatory Blood Pressure Monitors Market - Competitive Landscape

Major players operating in the global ambulatory blood pressure monitors market include OSI Systems Inc., SunTech Medical Inc., Andon Health Co. Ltd., Schiller AG, Omron Healthcare Co. Ltd., Beurer GmBH, Finapres Medical Systems B.V., Welch Allyn, Inc., and Koninklijke Philips N.V.